- 1、本文档共66页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
PharmaceuticalQualitybyDesign
2006.08.22. Pogány - Dar es Salaam */66 Manufacturing Process Development An assessment of the ability of the process to reliably produce a product of the intended quality e.g., the performance of the manufacturing process under different operating conditions, at different scales, or with different equipment can be provided. Unsatisfactory processes must be modified and improved until a validation exercise proves them to be satisfactory. An understanding of process robustness can be useful in risk assessment and risk reduction. 2006.08.22. Pogány - Dar es Salaam */66 The remaining steps Pharmaceutical equivalence and bioequivalence with innovator product has been demonstrated Production batches validated Compilation of the dossier for prequalification Prequalification procedure GMP inspection Listing the FPP on the PQ website 2006.08.22. Pogány - Dar es Salaam */66 Main points again Development pharmaceutics is an essential part of applications for prequalification. Desk research gives valuable design and development information. The specifications of an API are finalized during pharmaceutical development studies. FPP design, characterization and selection should follow a scientific methodology. Manufacturing process design and optimization identifies the critical attributes whose control leads to the batch-to-batch consistency of quality. 2006.08.22. Pogány - Dar es Salaam */66 THANK YOU * * * * * FOURTH INVITATION FOR EXPRESSION OF INTEREST (EOI) (Artemisinin based Antimalarial Products) May 2005 In the context of facilitating access to Artemisinin based combination antimalarial drug products, Roll Back Malaria (RBM) Department of the World Health Organization, UNICEF and UNDP are inviting Expressions of Interest from manufacturers of pharmaceutical products in respect to the provision of drugs for the management of malaria. The World Bank is in support of this effort. This fourth invitation is published in order to increase the range of possible product
您可能关注的文档
- PPT-关注幼儿的发展再谈幼儿园集中教育活动设计.ppt
- PPT-冬春季学校常见传染病及防控管理要求.ppt
- ppt-安全生产知识培训教案.ppt
- polycom hdx8000视频终端应用手册[精华].ppt
- PPT-班主任的智慧—中小学班主任工作案例分析.ppt
- PPT-第二章国际法的基本原则.ppt
- polycom hdx8000视频终端使用手册.ppt.ppt
- ppt-第二章国际法的基本原则(FundamentalPrinciplesofInt.L.).ppt
- PPT-第七章生产作业计划第一节期量标准.ppt
- PPT-第十三章项目管理软件及其应用.ppt
- 区块链技术在元宇宙基础设施中的应用与优化策略深度研究报告.docx
- 2025年分布式能源系统中生物质能源应用的设备选型与配置优化报告.docx
- 2025年学前教育师资队伍教师培训课程体系构建与实施报告.docx
- 企业文化建设与品牌价值提升.docx
- 2025年教育培训行业报告:教育培训机构品牌建设与市场拓展策略.docx
- 水产养殖水质AI诊断项目创业计划书.docx
- 2025年农业废弃物能源化利用技术成果鉴定与经济效益评估报告.docx
- 金融市场中量化投资策略在金融市场风险防范中的应用与风险预警.docx
- 汽车共享平台在2025年的智能化运营与用户行为演变报告.docx
- 中新赛克武汉市专.pdf
文档评论(0)